Clinical Trial Management System Market Gains Momentum as More Than 200 Companies Adopt Veeva CTMS

The Clinical Trial Management System (CTMS) market is gaining traction as digital platforms become central to increasingly complex clinical research operations. In January 2025, Veeva Systems announced that more than 200 companies, including 17 of the top 20 biopharmaceutical companies, were using Veeva CTMS to improve trial efficiency and collaboration. The adoption highlights growing demand for centralized trial data, enrollment tracking, milestone management, monitoring, and compliance capabilities, strengthening opportunities for cloud-based CTMS providers.

Veeva Systems, Oracle, IQVIA, Medidata, and Clario are positioned to benefit as pharmaceutical companies, biotechnology firms, and CROs modernize clinical operations. Veeva expanded its offering in April 2025 with SiteVault CTMS for research sites, integrating CTMS with electronic investigator site files and eConsent. Such developments create opportunities for cloud deployment, integrated clinical workflows, site-level solutions, automated reporting, and stronger sponsor-CRO collaboration, while increasing competitive pressure on legacy and standalone systems.

The global Clinical Trial Management System Market is estimated at approximately USD 2.28 billion in 2025 and is projected to reach USD 4.2 billion by 2031, registering a CAGR of 14.6% during the forecast period 2026 to 2031. The market covers software and services used to plan, manage, monitor and oversee clinical trials, including study planning, site management, participant tracking, reporting and regulatory activities. Increasing clinical trial activity, rising pharmaceutical and biotechnology R&D spending, cloud-based platforms, AI adoption and the need for better trial oversight are supporting market growth.

Download Free Sample PDF of the Report: https://www.datamintelligence.com/download-sample/clinical-trial-management-system-market?akash

Clinical Trial Management System Market Recent Developments

U.S. Recent Developments

• September 2026 - IQVIA: IQVIA announced its Predictive Clinical Development approach, an AI-powered model designed to improve clinical development efficiency. The company reported capabilities including faster study startup, AI-prioritized patient recruitment, faster data cleaning and shorter transitions between trial phases.

• April 2026 - Medidata and Worldwide Clinical Trials: Medidata and Worldwide Clinical Trials announced a strategic partnership to deploy Medidata Plus across Worldwide's clinical trial operations. Worldwide became the first global CRO to implement Medidata Plus, gaining access to AI capabilities across study, data and patient experiences.

• February 2026 - Medidata: Medidata reported that its AI technologies had been used across more than 500 clinical studies over the previous decade, including more than 120 AI-supported studies beginning in 2025. The company also introduced enhancements to Medidata Designer through AI-supported study build capabilities.

Japan Recent Developments

• September 2026 - Medidata: Medidata's NEXT Shanghai 2026 program highlighted AI applications across the clinical trial lifecycle as China-based biopharma companies increasingly expand global development programs. The company also highlighted its presence across international markets including Tokyo.

• April 2026 - IQVIA: IQVIA highlighted digital protocols as a foundation for more automated clinical trial workflows. The company noted that structured digital protocols can support study startup, data monitoring, electronic data capture and downstream clinical technology integration.

• 2026 - Veeva Systems: Veeva's 2026 clinical data releases added capabilities focused on audit trails, data quality, clinical reporting and automated data workflows. The 26R2 release also introduced Veeva DQS as the company's dedicated Data Quality System.

Speak to Our Analyst and Get Customization in the Report as per Your Requirements:

https://www.datamintelligence.com/customize/clinical-trial-management-system-market?akash

Clinical Trial Management System Market Mergers and Acquisitions

• 2026 - Clinical technology consolidation: Clinical research technology providers continued expanding through AI, data-management and workflow capabilities as sponsors and CROs seek more connected clinical trial systems.

• 2026 - Medidata and Worldwide Clinical Trials: The strategic agreement between Medidata and Worldwide Clinical Trials expanded the use of Medidata's AI capabilities across clinical study execution and delivery.

• 2026 - Technology integration: Clinical technology companies are increasingly combining clinical data, study management, patient experience and AI capabilities to support more connected trial operations. Medidata's CTMS platform, for example, brings clinical and operational activities into a connected AI-enabled environment.

Clinical Trial Management System Market Segmentation

By Type - 62.4%
On-Site CTMS
Enterprise-wide CTMS

By Mode of Delivery - 41.5%
Web-based
On-premise
Cloud-based

By End User - 52.8%
Pharmaceuticals & Biotechnology Companies
CROs
Research Hospitals

The software segment is expected to hold the dominant position, accounting for 40.6% of the market over the forecast period.

Clinical Trial Management System Market Regional Share

North America is the largest region, accounting for 40.7% of the global Clinical Trial Management System Market. The United States is the largest contributor within the region, supported by high clinical research activity, pharmaceutical R&D spending and demand for technologies that improve clinical trial management.

The U.S. remains a major clinical research market, with strong demand for CTMS platforms that support study startup, site management, monitoring, data oversight and reporting. IQVIA's 2026 predictive clinical development offering demonstrates the increasing use of AI and data-driven workflows in U.S.-based clinical research.

Japan continues to adopt digital clinical research technologies as clinical development becomes more data-intensive. Digital protocols, connected clinical systems and AI-supported workflows are creating opportunities for CTMS and related clinical technology platforms.

Clinical Trial Management System Market Key Players

• Oracle
• IQVIA Inc.
• RealTime Software Solutions, LLC
• Medidata (Dassault Systèmes)
• Clario

Oracle provides clinical research technology through its Life Sciences portfolio, including Oracle Clinical One for clinical trial management and related study technologies. Its platform supports study management, analytics, randomization, trial supply and other clinical research workflows.

Medidata, a Dassault Systèmes brand, provides clinical trial technology covering study, data and patient experiences. Its CTMS connects clinical and operational activities and incorporates AI-enabled capabilities for study planning, monitoring, issue management and reporting.

Conclusion

The clinical trial management system Market is expanding as pharmaceutical companies, biotechnology firms, CROs and research organizations seek better ways to manage increasingly complex clinical studies. Cloud-based deployment, integrated clinical platforms, real-time oversight and AI-supported workflows are becoming increasingly important for improving trial coordination and data visibility.

Unlock Complete Market Intelligence with the Full Report: https://www.datamintelligence.com/buy-now-page?report=clinical-trial-management-system-market?akash

FAQs

1. What is driving Clinical Trial Management System Market growth?

2. Which region dominates the Clinical Trial Management System Market?

3. What is the Clinical Trial Management System Market forecast?

Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About Us :
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.